Fina Biosolutions announces that the United States Patent and Trademark Office has issued a patent for expression and purification of the conjugate vaccine protein CRM197 in E. coli. CRM197 is a key component of many vaccine formulations utilized worldwide.
{iframe}https://www.businesswire.com/news/home/20180927005091/en/Fina-Biosolutions-Announces-New-Patent-Conjugate-Vaccine{/iframe}